7-Methoxy-8-{(1-(3-(4-((E)-3-(2-hydroxyphenyl)-3-oxoprop-1-enyl)-2-methoxyphenoxy)propyl)-1H-1,2,3-triazol-4-yl)methoxy}-(11aS)-1,2,3,11atetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one

ID: ALA1823737

Chembl Id: CHEMBL1823737

PubChem CID: 54769565

Max Phase: Preclinical

Molecular Formula: C35H35N5O7

Molecular Weight: 637.69

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C/C(=O)c2ccccc2O)ccc1OCCCn1cc(COc2cc3c(cc2OC)C(=O)N2CCC[C@H]2C=N3)nn1

Standard InChI:  InChI=1S/C35H35N5O7/c1-44-32-17-23(10-12-30(42)26-8-3-4-9-29(26)41)11-13-31(32)46-16-6-14-39-21-24(37-38-39)22-47-34-19-28-27(18-33(34)45-2)35(43)40-15-5-7-25(40)20-36-28/h3-4,8-13,17-21,25,41H,5-7,14-16,22H2,1-2H3/b12-10+/t25-/m0/s1

Standard InChI Key:  BPDDHMZGAHCLSN-DWOOMVRVSA-N

Associated Targets(Human)

COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ZR-75-1 (953 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SiHa (2051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCND1 Tchem G1/S-specific cyclin D1 (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 637.69Molecular Weight (Monoisotopic): 637.2536AlogP: 5.27#Rotatable Bonds: 13
Polar Surface Area: 137.60Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.19CX Basic pKa: 4.06CX LogP: 4.74CX LogD: 4.33
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.12Np Likeness Score: -0.37

References

1. Kamal A, Prabhakar S, Janaki Ramaiah M, Venkat Reddy P, Ratna Reddy Ch, Mallareddy A, Shankaraiah N, Lakshmi Narayan Reddy T, Pushpavalli SN, Pal-Bhadra M..  (2011)  Synthesis and anticancer activity of chalcone-pyrrolobenzodiazepine conjugates linked via 1,2,3-triazole ring side-armed with alkane spacers.,  46  (9): [PMID:21676506] [10.1016/j.ejmech.2011.05.050]

Source